Craniotomy

A craniotomy is a major neurosurgical procedure in which a section of the skull is temporarily removed to gain access to the brain for treating tumours, bleeding, aneurysms or other intracranial conditions. It is one of the most fundamental techniques in neurosurgery, forming the access route for a wide range of brain operations rather than being a treatment in itself. Advanced imaging and neuronavigation systems are used to plan the exact location and size of the bone opening needed for each specific condition. Recovery and outcomes vary considerably depending on the underlying disease being treated and the areas of the brain involved.

Craniotomy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Neurosurgery specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 6-12 weeks recovery. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Intensive care monitoring is required for the first twenty-four to forty-eight hours, with a hospital stay of five to ten days depending on the condition treated. Neurological function gradually returns over weeks to months, rehabilitation therapy is often needed, and full recovery can take several months.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Craniotomy has a documented success rate of 80-90% (varies significantly by underlying condition) at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.